Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|September 18, 2015
Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCASTDerek F J Brown, Mandy Wootton, Robin A HoweThe Journal of Antimicrobial Chemotherapy|January 25, 2017
Towards better antimicrobial susceptibility testing: impact of the Journal of Antimicrobial ChemotherapyMandy Wootton, Alasdair P MacGowan, Robin A HoweClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 30, 2020
Evaluation of susceptibility testing methods for Burkholderia cepacia complex: a comparison of broth microdilution, agar dilution, gradient strip and EUCAST disc diffusionMandy Wootton, Leanne Davies, Katherine Pitman, et al.The Journal of Antimicrobial Chemotherapy|November 17, 2009
Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporinsMandy Wootton, Tim R Walsh, Lorna Macfarlane, et al.Infection Control and Hospital Epidemiology|February 10, 2009
Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureusMandy Wootton, Timothy R Walsh, Eleri M Davies, et al.Journal of Clinical Microbiology|November 17, 2006
A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptidesMandy Wootton, Alasdair P MacGowan, Timothy R Walsh, et al.Emerging Infectious Diseases|June 18, 2004
Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineagesRobin A Howe, Alastair Monk, Mandy Wootton, et al.The Journal of Antimicrobial Chemotherapy|November 3, 2025
Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'Sara E Boyd, Mandy Wootton, Robin A Howe, et al.Antimicrobial Agents and Chemotherapy|October 25, 2003
Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolidRobin A Howe, Mandy Wootton, Alan R Noel, et al.Antimicrobial Agents and Chemotherapy|October 18, 2006
Comparative bactericidal activities of daptomycin and vancomycin against glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA isolatesMandy Wootton, Alasdair P MacGowan, Timothy R WalshPageof 10